To Evaluate the Efficacy and Safety of Micafungin in Preventing Invasive Mycosis After Liver Transplantation

NCT04728971 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Liver Transplantation

Interventions

DRUG: Micafungin Sodium 50 MG Injection
DRUG: Caspofungin Acetate

Sponsor

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine